Clinical Trial Update: Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating high-dose therapy with stem cell support followed by Rituximab and alpha interferon for follicular lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Alpha Interferon (interferon alfa)
• Rituximab (rituximab)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Follicular Lymphoma | Phase 2 | Status: COMPLETED